Buch
Clinical Use of Antibodies
-Tumours, infection, infarction, rejection and in the diagnosis of AIDS-Richard P. Baum; P.H. Cox; Gustav Hör; Gian Luigi Buraggi (Hrsg.)
106,99
EUR
Lieferzeit 12-13 Tage
Übersicht
Verlag | : | Springer Netherland |
Buchreihe | : | Developments in Nuclear Medicine (Bd. 19) |
Sprache | : | Englisch |
Erschienen | : | 05. 11. 2012 |
Seiten | : | 185 |
Einband | : | Kartoniert |
Höhe | : | 235 mm |
Breite | : | 155 mm |
Gewicht | : | 314 g |
ISBN | : | 9789401055550 |
Sprache | : | Englisch |
Inhaltsverzeichnis
1. Advances in cancer imaging and therapy with radiolabelled antibodies.- 2. Evaluation of the diagnostic utility of immunoscintigraphy in oncology.- 3. The quality control and clinical testing of radiolabelled antibodies.- 4. Clinical utility of radiolabelled monoclonal antibodies in the management of gastrointestinal cancer.- 5. Use of 123-I radiolabelled F(AB’)2 fragments of anti-CEA monoclonal antibody for the detection of primary and metastatic gastrointestinal carcinomas.- 6. Bispecific monoclonal antibodies for two phase radioimmunotherapy.- 7. Antimyosin antibody imaging in myocardial infarction.- 8. Antimyosin based radioimmunodetection of myocarditis cardiomyopathy and cardiac transplant rejection.- 9. Recent advances in the use of radiolabelled monoclonal antibodies in the management of ovarian cancer.- 10. Monoclonal antibodies for cell labelling with particular reference to thrombus imaging.- 11. The role of nuclear medicine in the evaluation of the patient with acquired immune deficiency syndrome (AIDS).- 12. Detection of inflammation/infection using radiolabelled anti-granulocyte antibodies: possibilities and limitations.- 13. A new marker for the detection of adenocardinomas by radioimmunoscintigraphy.- 14. New developments in the diagnosis of AIDS and strategies for therapy.
Pressestimmen
'To conclude, this is a summary of research findings in Nuclear Medicine of predominant interest to Nuclear Medicine Physicians particularly those interested in "magic bullets", especially biological ones.' Australian Cancer Society 16:3 1992